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1. Introduction 
A traditional question confronting investigators of 
a protein structure is to what extent may we transfer 
X-ray data for proteins in crystal to their structures 
in solution. To answer this question, a method of 
large-angle diffuse X-ray scattering was proposed in 
our laboratory [ 1,2] having high sensitivity to details 
of an internal structure of globular proteins [l-3]. 
The use of this method for a direct comparison of 
protein structures in crystal and in solution is based 
on the calculation of a scattering curve from protein 
X-ray atomic coordinates (taking into account solvent 
influence) [4,5] and on a comparison of the obtained 
theoretical scattering curve with the experimental one 
in solution. The region of scattering angles, in which 
there are differences between these curves, allows to 
form an opinion about the scale of distances affected 
by these differences. 
In this paper the above method was used to com- 
pare the structures of ribonuclease and its complex 
with the inhibitor in crystal and in solution. It was 
shown that on a distance scale > 10 A the structures 
of both ribonuclease and its complex with the inhibitor 
in solution do not differ from their crystalline 
structures. 
2. Materials and methods 
.Bovine pancreatic ribonuclease A was isolated in 
the laboratory of M. Ya. Karpeisky (Institute of 
Molecular Biology, USSR Academy of Sciences) and 
was kindly provided for our investigations. The con- 
current inhibitor was isolated from a mixture of 
Elsevier/North-Holland Biomedical Press 
2’.CMP and 3P-CMP as in [6]. The solutions of the 
enzyme and its complex with the inhibitor were 
investigated in a 0.2 M Na-acetate buffer at 2 1 .O + 
0.5’C, pH 5.4 (at which the protein-inhibitor binding 
constant is close to the maximal one [7]). The binding 
of the inhibitor with the enzyme was tested by 
ultraviolet difference spectra at X = 260 nm. The 
preservation of enzymatic activity before and after 
X-ray measurements was checked by the increase of 
ultraviolet absorbance at A = 260 nm on splitting of 
RNA. The scattering curves were obtained with the 
equipment in [8]. The maximal statistical error in the 
determination of intensities did not exceed 1% at 
minimal scattering angles and 5% at maximal ones. 
The curve for ribonuclease was measured 4 times for 
two different species, the curve for ribonuclease-2’. 
CMP complex was measured 3 times; fig.1 -3 represent 
averaged curves. 
For a more strict comparison of the experimental 
curves with the theoretical ones we did not undertake 
a slit desmearing but compared the experimental 
curves with the theoretical ones which were ‘smeared’ 
taking into account the parameters of our collimation 
slits (the distribution of an incident beam intensity 
along the height has a trapezium-like shape with bases 
of 32.2 mm and 58.4 mm, the receiver slit length is 
16.7 mm and the sample-receiver distance is 204 mm). 
3. Results and discussion 
To investigate the influence of a possible association 
of molecules as well as intermolecular interference on 
scattering curves, the latter were measured at 5 con- 
centrations from 39.0-13.8 mg/ml. The scattering 
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Table 1 
Values of molecular weights and gyration radii 
April 1978 
Sample Molecular weight Gyration radius 
(MX 10-3) Rg (A) 
Exp. talc . Exp. Calc. 
Ribonuclease 13.3 * 1.0 13.7 15.9 * 0.5 15.0 
Ribonuclease-Z’CMP 15.5 i 1.0 14.0 16.4 + 0.6 14.8 
curves (calculated per molecule) did not depend on 
concentration at p ? 0.1 A-’ , where 
I* = (4 n/X) . Sin 0 
(h = 1.5 A is an X-ray wavelength, 2 0 is the 
scattering angle.) For both ribonuclease A and its 
complex with 2’CMP an extrapolation of small-angle 
scattering data to zero concentration gave the values 
of molecular weights M and gyration radii R, close to 
those calculated from the chemical composition and 
the X-ray atomic coordinates, respectively (table 1). 
As X-ray atomic coordinates of ribonuclease A are 
not yet available, we compared our experimental 
curves with those calculated from X-ray atomic 
coordinates of ribonuclease S [9 ] and its complex 
with 2’-CMP [lo] (the same X-ray atomic coordinates 
were used for R, calculation in table 1). Such a 
comparison is meaningful because the main chain 
course of ribonuclease S [9] differs from that of 
ribonuclease A [ 111 only in a small region of the 
molecule (from residues 18-23) close to the rupture 
of the bond between residues 20 and 21. Moreover, 
our calculations have shown that the model displace- 
ment of the S-peptide in the ribonuclease S [9] 
relative to its position in the ribonuclease A [ 1 l] did 
not in practice influence the scattering curve. 
The scattering curve calculation was made by the 
‘cube method’ [3,4] taking into account solvent 
influence. The method was modified to take into con- 
sideration more exactly cavities and clefts in a protein 
molecule accessible to the solvent. The scattering 
curves for ribonuclease S and its complex with 
2’-CMP calculated by this method are plotted in fig.1 as 
log a”r (~1) versus p 
where & is a scattering intensity of one molecule, 
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Fig.1. Comparison of the theoretical scattering curves for 
ribonuclease S ( -) and its complex with Z’CMP (---). 
‘smeared’ taking into account real geometry of the 
slits used. According to the data of paper [lo] the 
inhibitor binding does not cause noticeable changes 
of ribonuclease structure, therefore any differences 
between the curves can be due only to the contribu- 
tion of the inhibitor altering the molecular weight to 
which it contributes only - 2% of the molecular 
weight of the complex. Figure 1 shows that the 
inhibitor binding without any alterations in the protein 
structure noticeably changes the calculated curve, 
which provides evidence once again about the high 
sensitivity of the method (cf. [l-3]). 
In fig.2 the experimental scattering curve for ribo- 
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Fig.2. Comparison of the theoretical scattering curvy (-) 
with the experimental one for ribonuclease (. . .). AZ is a 
scattering intensity extrapolated to zero concentration 
(impulses per second) calculated per macromolecule. 
nuclease A is compared with the scattering curve 
calculated from X-ray atomic coordinates of ribo- 
nuclease S. The comparison of the curves was done at 
an absolute intensity scale calculated per macro- 
molecule. The divergence between experimental and 
theoretical values did not exceed a systematic error in 
the calculation of the absolute scale (- 10%) which 
allowed one to superpose the absolute values to 
facilitate comparison of the curves. Figure 2 shows 
that the curves coincide well at all the angle intervals 
measured (II < 0.5 A-‘) corresponding to Bragg’s 
distances 
d = X/(2 Sin 0) 2 10 A 
This shows that the ribonuclease structure in solu- 
tion practically coincides with its crystal structure at 
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Fig.3. Comparison of the theoretical scattering curve (-) 
with the experimental one for ribonuclease-Z’CMP complex 
(. . .). 
a distance scale >, 10 A. A comparison of the laser 
Raman scattering spectra of ribonuclease A in 
crystal and in solution [ 121 has already indicated the 
absence of noticeable changes in internal rotation 
angles of the main chain (averaged over the whole 
molecule). Our results indicate the absence of notice- 
able displacements of large masses of the molecule 
caused by changes of angles in short segments of the 
chain. 
Figure 3 represents an analogous comparison for 
the scattering curves of the ‘ribonuclease-2’CMP 
complex. Figure 3 shows that the structure of the 
complex in solution practically coincides with its 
crystalline structure. This means, in particular, that in 
the given case (in contrast to hen egg-white lysozyme 
[ 11) binding of the inhibitor does not result in a 
noticeable change of the protein structure, not only 
in crystal but also in solution. 
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